Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 569
2021 387
2022 118
2023 49
2024 26
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

569 results

Results by year

Filters applied: . Clear all
Page 6
A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
Najar Nobari N, Seirafianpour F, Mashayekhi F, Goodarzi A. Najar Nobari N, et al. Dermatol Ther. 2021 Jan;34(1):e14662. doi: 10.1111/dth.14662. Epub 2020 Dec 26. Dermatol Ther. 2021. PMID: 33301232 Free PMC article.
Most of drugs could have certain mucocutaneous reactions and COVID-19 drugs are not an exception that we focused. We systematically reviewed databases until August 15, 2020 and among initial 851 articles, 30 articles entered this study (20 case reports, 4 cohorts, a …
Most of drugs could have certain mucocutaneous reactions and COVID-19 drugs are not an exception that we focused. We systemati …
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Rosenthal N, et al. JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058. JAMA Netw Open. 2020. PMID: 33301018 Free PMC article.
There is a dearth of research on epidemiology and clinical outcomes in US patients with COVID-19. OBJECTIVES: To characterize patients with COVID-19 treated in US hospitals and to examine risk factors associated with in-hospital mortality. ...CONCLUSIO …
There is a dearth of research on epidemiology and clinical outcomes in US patients with COVID-19. OBJECTIVES: To characterize …
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability.
El Ouarradi A, Abdeladim S, Oualim S, Filali RA, Bensahi I, Elharass M, Hafid S, Tazi H, Naitlhou A, Bouaiti EA, Moustaghfir A, Sabry M. El Ouarradi A, et al. J Saudi Heart Assoc. 2020 Aug 19;32(3):350-357. doi: 10.37616/2212-5043.1088. eCollection 2020. J Saudi Heart Assoc. 2020. PMID: 33299775 Free PMC article.
During the COVID-19 pandemic, the effectiveness of the combination of hydroxychloroquine and azithromycin is widely discussed. ...The aim of this study is to describe the cardiovascular effect of hydroxychloroquine and azithromycin by ana …
During the COVID-19 pandemic, the effectiveness of the combination of hydroxychloroquine and azithromycin is wid …
A case of severe course of COVID-19 treated with experimental therapy.
Zlámal M, Štěchovská K, Holub M. Zlámal M, et al. Cas Lek Cesk. 2020 Summer;159(5):181-184. Cas Lek Cesk. 2020. PMID: 33297704 English.
70-year-old high-risk patient with severe course of COVID-19 hospitalized for progressive dyspnea due to extensive bilateral pneumonia caused by SARS-CoV-2. ...Risk factors of severe course of the infection, complications and potential therapies …
70-year-old high-risk patient with severe course of COVID-19 hospitalized for progressive dyspnea due to extensive bilateral p …
Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study.
Ashinyo ME, Duti V, Dubik SD, Amegah KE, Kutsoati S, Oduro-Mensah E, Puplampu P, Gyansa-Lutterodt M, Darko DM, Buabeng KO, Ashinyo A, Ofosu AA, Baddoo NA, Akoriyea SK, Ofei F, Kuma-Aboagye P. Ashinyo ME, et al. Pan Afr Med J. 2020 Sep 15;37(Suppl 1):9. doi: 10.11604/pamj.supp.2020.37.9.25718. eCollection 2020. Pan Afr Med J. 2020. PMID: 33294110 Free PMC article.
INTRODUCTION: COVID-19 is a global pandemic seen in modern times. The clinical characteristics, treatment regimen and duration of hospitalization of COVID-19 patients remain unclear in Ghana. METHODS: we retrospectively reviewed the secondary data of 3 …
INTRODUCTION: COVID-19 is a global pandemic seen in modern times. The clinical characteristics, treatment regimen and duration …
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients.
Jiménez-Jáimez J, Macías-Ruiz R, Bermúdez-Jiménez F, Rubini-Costa R, Ramírez-Taboada J, Flores PIG, Gallo-Padilla L, García JDM, García CM, Suárez SM, Molina CF, López MÁ, Tercedor L. Jiménez-Jáimez J, et al. Sci Rep. 2020 Dec 8;10(1):21417. doi: 10.1038/s41598-020-78360-9. Sci Rep. 2020. PMID: 33293554 Free PMC article.
SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxicloroquine, azitromycin and protease inhibitors is being empirically used, with reported data of QTc interval prolongation. ...Ambulatory and not critically il …
SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxicloroquine, azitrom …
Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19.
Seyhan AU, Doganay F, Yilmaz E, Topal NP, Ak R. Seyhan AU, et al. J Coll Physicians Surg Pak. 2020 Oct;30(10):153-157. doi: 10.29271/jcpsp.2020.supp2.S153. J Coll Physicians Surg Pak. 2020. PMID: 33291194
OBJECTIVE: To assess and identify the risk of prolonged QT about hydroxychloroquine (HQ) and azithromycin (AZ) used in the treatment of patients with COVID-19. ...We concluded that this increase in QTc did not cause ventricular arrhythmia. Key Words: …
OBJECTIVE: To assess and identify the risk of prolonged QT about hydroxychloroquine (HQ) and azithromycin (AZ) used in the tre …
A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2.
Kivrak A, Ulaş B, Kivrak H. Kivrak A, et al. Int Immunopharmacol. 2021 Jan;90:107232. doi: 10.1016/j.intimp.2020.107232. Epub 2020 Nov 30. Int Immunopharmacol. 2021. PMID: 33290969 Free PMC article. Review.
Although, scientists focus on the finding novel drugs and vaccine for SARS-CoV-2, there is no certain treatment for it. Antiviral drugs such as; oseltamivir, favipiravir, umifenovir, lopinavir, remdesivir, hydroxychloroquine, chloroquine, azithromyc …
Although, scientists focus on the finding novel drugs and vaccine for SARS-CoV-2, there is no certain treatment for it. …
The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
Shamshirian A, Hessami A, Heydari K, Navaei RA, Ebrahimzadeh MA, Yip GW, Ghasemian R, Sedaghat M, Baradaran H, Yazdi SM, Aboufazeli E, Jafarpour H, Dadgostar E, Tirandazi B, Sadeghnezhad R, Karimifar K, Eftekhari A, Shamshirian D. Shamshirian A, et al. Ann Acad Med Singap. 2020 Oct;49(10):789-800. Ann Acad Med Singap. 2020. PMID: 33283842 Free article.
OBJECTIVE: A systematic review and meta-analysis was carried out to examine the role of hydroxychloroquine (HCQ) in the treatment of COVID-19. METHODS: We performed a systematic search in PubMed, Scopus, Embase, CochraneLibrary, Web of Science, Google Scholar …
OBJECTIVE: A systematic review and meta-analysis was carried out to examine the role of hydroxychloroquine (HCQ) in the treatment of …
Pulmonary Embolism in COVID-19 Pneumonia: An Overlapping Diagnosis or a Misdiagnosis?
Secco E, Pasqualetto MC, Rigo F. Secco E, et al. J Cardiovasc Echogr. 2020 Apr-Jun;30(2):110-112. doi: 10.4103/jcecho.jcecho_43_20. Epub 2020 Aug 17. J Cardiovasc Echogr. 2020. PMID: 33282650 Free PMC article.
Coronavirus pneumonia (COVID-19) is a novel infectious disease with a high mortality rate due to severe acute respiratory syndrome. ...Although azithromycin and hydroxychloroquine were promptly administered, she had a worsening of dyspnea even with a h …
Coronavirus pneumonia (COVID-19) is a novel infectious disease with a high mortality rate due to severe acute respiratory synd …
569 results